Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Plaque Reduction Neutralization Test (PRNT) Accuracy in Evaluating Humoral Immune Response to SARS-CoV-2.
Diseases. 2024 Jan 18;12(1):29. doi: 10.3390/diseases12010029.
Diseases. 2024.
PMID: 38248380
Free PMC article.
Inhibition of SARS-CoV-2 Infection in Vero Cells by Bovine Lactoferrin under Different Iron-Saturation States.
Alves NS, Azevedo AS, Dias BM, Horbach IS, Setatino BP, Denani CB, Schwarcz WD, Lima SMB, Missailidis S, Ano Bom APD, Silva AMV, Barreto Vieira DF, Silva MAN, Barros CA, Carvalho CAM, Gonçalves RB.
Alves NS, et al. Among authors: denani cb.
Pharmaceuticals (Basel). 2023 Sep 25;16(10):1352. doi: 10.3390/ph16101352.
Pharmaceuticals (Basel). 2023.
PMID: 37895823
Free PMC article.
Item in Clipboard
Protective Immunity of COVID-19 Vaccination with ChAdOx1 nCoV-19 Following Previous SARS-CoV-2 Infection: A Humoral and Cellular Investigation.
Azamor T, Horbach IS, Brito E Cunha D, Melgaço JG, Silva AMVD, Tubarão LN, Azevedo AS, Santos RT, Alves NDS, Machado TL, Silva J, Souza AF, Bayma C, Rocha VP, Frederico ABT, Dias BM, Setatino BP, Denani CB, Campos SPDC, Schwarcz WD, Sucupira MV, Mendes EP, Silva EDD, Barbosa de Lima SM, Ano Bom APD, Missailidis S.
Azamor T, et al. Among authors: denani cb.
Viruses. 2022 Aug 30;14(9):1916. doi: 10.3390/v14091916.
Viruses. 2022.
PMID: 36146723
Free PMC article.
Item in Clipboard
Effectiveness, safety, and immunogenicity of half dose ChAdOx1 nCoV-19 COVID-19 Vaccine: Viana project.
Valim V, Martins-Filho OA, Gouvea MDPG, Camacho LAB, Villela DAM, de Lima SMB, Azevedo AS, Neto LFP, Domingues CMAS, de Medeiros Junior NF, Moulaz IR, Dias LH, Miyamoto ST, Teixeira-Carvalho A, Mill JG; Half Dose ChAdOx Study Group.
Valim V, et al.
Front Immunol. 2022 Aug 29;13:966416. doi: 10.3389/fimmu.2022.966416. eCollection 2022.
Front Immunol. 2022.
PMID: 36105814
Free PMC article.
Clinical Trial.
Item in Clipboard
Lactoferrin affects rhinovirus B-14 entry into H1-HeLa cells.
Denani CB, Real-Hohn A, de Carvalho CAM, Gomes AMO, Gonçalves RB.
Denani CB, et al.
Arch Virol. 2021 Apr;166(4):1203-1211. doi: 10.1007/s00705-021-04993-4. Epub 2021 Feb 19.
Arch Virol. 2021.
PMID: 33606112
Free PMC article.
Item in Clipboard
Impairing the function of MLCK, myosin Va or myosin Vb disrupts Rhinovirus B14 replication.
Real-Hohn A, Provance DW Jr, Gonçalves RB, Denani CB, de Oliveira AC, Salerno VP, Oliveira Gomes AM.
Real-Hohn A, et al. Among authors: denani cb.
Sci Rep. 2017 Dec 7;7(1):17153. doi: 10.1038/s41598-017-17501-z.
Sci Rep. 2017.
PMID: 29215055
Free PMC article.
Item in Clipboard
Cite
Cite